Chris Francis - Jan 1, 2022 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role
SVP, Corporate Development, Head of Emerging Areas
Signature
/s/ Chris Francis
Stock symbol
WVE
Transactions as of
Jan 1, 2022
Transactions value $
$0
Form type
4
Date filed
1/4/2022, 08:16 PM
Next filing
Feb 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WVE Share Option (right to buy) Award $0 +150K $0.00 150K Jan 1, 2022 Ordinary Shares 150K $3.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the shares on January 1, 2023 and vests as to an additional 6.25% of the shares quarterly thereafter until January 1, 2026.

Remarks:

SVP, Corporate Development, Head of Emerging Areas